HK1011382A1 - Chimeric selectins by exchange of domains - uses thereof - Google Patents
Chimeric selectins by exchange of domains - uses thereofInfo
- Publication number
- HK1011382A1 HK1011382A1 HK98112555A HK98112555A HK1011382A1 HK 1011382 A1 HK1011382 A1 HK 1011382A1 HK 98112555 A HK98112555 A HK 98112555A HK 98112555 A HK98112555 A HK 98112555A HK 1011382 A1 HK1011382 A1 HK 1011382A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- polypeptides
- domains
- chimeric
- lectin
- peptides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/7056—Lectin superfamily, e.g. CD23, CD72
- C07K14/70564—Selectins, e.g. CD62
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
- C07K16/2854—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72 against selectins, e.g. CD62
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US845993A | 1993-01-25 | 1993-01-25 | |
PCT/US1994/000909 WO1994017193A2 (en) | 1993-01-25 | 1994-01-25 | Chimeric l- and p-selectin by exchange of domains - uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1011382A1 true HK1011382A1 (en) | 1999-07-09 |
Family
ID=21731721
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98112555A HK1011382A1 (en) | 1993-01-25 | 1998-11-30 | Chimeric selectins by exchange of domains - uses thereof |
Country Status (14)
Country | Link |
---|---|
US (2) | US5808025A (ja) |
EP (1) | EP0689599B1 (ja) |
JP (1) | JPH08506017A (ja) |
AT (1) | ATE174344T1 (ja) |
AU (1) | AU694933B2 (ja) |
CA (1) | CA2153802A1 (ja) |
DE (1) | DE69415154T2 (ja) |
DK (1) | DK0689599T3 (ja) |
ES (1) | ES2126742T3 (ja) |
GR (1) | GR3029640T3 (ja) |
HK (1) | HK1011382A1 (ja) |
NZ (1) | NZ261991A (ja) |
SG (1) | SG48892A1 (ja) |
WO (1) | WO1994017193A2 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5648458A (en) * | 1992-05-06 | 1997-07-15 | Affymax Technologies N.V. | Peptides and compounds that bind to ELAM-1 |
US5728802A (en) * | 1992-05-06 | 1998-03-17 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1) |
US5643873A (en) * | 1992-05-06 | 1997-07-01 | Affymax Technologies N.V. | Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1 |
US20020040008A1 (en) * | 1995-01-24 | 2002-04-04 | Wagner Denisa D. | Method for treating and preventing atherosclerosis |
US7744888B2 (en) * | 2001-08-03 | 2010-06-29 | Abgenomics Cooperatief U.A. | Methods of modulating T cell or natural killer cell activity with anti-P-selectin glycoprotein ligand 1 antibodies |
US20040116333A1 (en) | 2001-08-03 | 2004-06-17 | Rong-Hwa Lin | Modulators of P-selectin glycoprotein ligand 1 |
US7169376B2 (en) * | 2004-06-10 | 2007-01-30 | Chevron U.S.A. Inc. | Method for making hydrogen using a gold containing water-gas shift catalyst |
MY148646A (en) * | 2004-05-10 | 2013-05-15 | Abgenomics Cooperatief Ua | Anti-psgl-1 antibodies |
AR048840A1 (es) * | 2004-05-11 | 2006-05-31 | Boehringer Ingelheim Int | Epitopes inductores de la muerte de las celulas t |
CA2838952C (en) | 2011-06-13 | 2020-11-24 | Stefan Bassarab | Anti-psgl-1 antibodies and uses thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4783330A (en) * | 1984-11-15 | 1988-11-08 | New England Medical Center Hospitals, Inc. | Monoclonal antibodies to activated platelets |
US5081034A (en) * | 1988-11-14 | 1992-01-14 | Brigham & Women's Hospital | Cloned genes which encode elam-1 |
US5098833A (en) * | 1989-02-23 | 1992-03-24 | Genentech, Inc. | DNA sequence encoding a functional domain of a lymphocyte homing receptor |
US5216131A (en) * | 1989-02-23 | 1993-06-01 | Genentech, Inc. | Lymphocyte homing receptors |
US5116964A (en) * | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
US5026537A (en) * | 1989-04-06 | 1991-06-25 | Centocor, Inc. | Methods for imaging atherosclerotic plaque |
WO1991007993A1 (en) * | 1989-11-30 | 1991-06-13 | Mathew Vadas | Anti-inflammatory and anti-adhesive factors |
US5709859A (en) * | 1991-01-24 | 1998-01-20 | Bristol-Myers Squibb Company | Mixed specificity fusion proteins |
AU2006792A (en) * | 1991-05-15 | 1992-12-30 | Dana-Farber Cancer Institute, Inc. | Leukocyte-associated cell surface protein |
-
1994
- 1994-01-25 EP EP94907889A patent/EP0689599B1/en not_active Expired - Lifetime
- 1994-01-25 JP JP6517291A patent/JPH08506017A/ja active Pending
- 1994-01-25 NZ NZ261991A patent/NZ261991A/en not_active IP Right Cessation
- 1994-01-25 AT AT94907889T patent/ATE174344T1/de not_active IP Right Cessation
- 1994-01-25 AU AU61284/94A patent/AU694933B2/en not_active Ceased
- 1994-01-25 SG SG1996003546A patent/SG48892A1/en unknown
- 1994-01-25 CA CA002153802A patent/CA2153802A1/en not_active Abandoned
- 1994-01-25 DK DK94907889T patent/DK0689599T3/da active
- 1994-01-25 DE DE69415154T patent/DE69415154T2/de not_active Expired - Fee Related
- 1994-01-25 WO PCT/US1994/000909 patent/WO1994017193A2/en active IP Right Grant
- 1994-01-25 ES ES94907889T patent/ES2126742T3/es not_active Expired - Lifetime
- 1994-11-16 US US08/340,539 patent/US5808025A/en not_active Expired - Lifetime
-
1995
- 1995-06-05 US US08/461,592 patent/US5834425A/en not_active Expired - Lifetime
-
1998
- 1998-11-30 HK HK98112555A patent/HK1011382A1/xx not_active IP Right Cessation
-
1999
- 1999-03-09 GR GR990400731T patent/GR3029640T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NZ261991A (en) | 1998-04-27 |
CA2153802A1 (en) | 1994-08-04 |
US5834425A (en) | 1998-11-10 |
WO1994017193A3 (en) | 1994-11-10 |
DE69415154T2 (de) | 1999-07-29 |
EP0689599B1 (en) | 1998-12-09 |
JPH08506017A (ja) | 1996-07-02 |
SG48892A1 (en) | 1998-05-18 |
ES2126742T3 (es) | 1999-04-01 |
GR3029640T3 (en) | 1999-06-30 |
EP0689599A1 (en) | 1996-01-03 |
ATE174344T1 (de) | 1998-12-15 |
AU694933B2 (en) | 1998-08-06 |
US5808025A (en) | 1998-09-15 |
AU6128494A (en) | 1994-08-15 |
WO1994017193A2 (en) | 1994-08-04 |
DK0689599T3 (da) | 1999-08-16 |
DE69415154D1 (de) | 1999-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1011382A1 (en) | Chimeric selectins by exchange of domains - uses thereof | |
WO1997021993A3 (en) | Nuclear receptor ligands and ligand binding domains | |
WO2004020405A3 (en) | Modified transferrin fusion proteins | |
WO1999026966A3 (en) | Nuclear receptor ligands and ligand binding domains | |
ZA200401079B (en) | Modified transferrin fusion proteins | |
EP0991618A4 (en) | SELECTIVE ANALOGS OF THYROID HORMONES | |
CA2100559A1 (en) | Domains of extracellular region of human platelet derived growth factor receptor polypeptides | |
GR3031720T3 (en) | Monoclonal antibodies against receptor-induced binding sites. | |
PT842273E (pt) | Ligando de receptor vegf-c | |
NO20000086D0 (no) | Chimerisk interleukin-6 opploeselig reseptor/ligandprotein, analoger derav og anvendelse av dette | |
SE8400865D0 (sv) | Platinaforening samt forfarande for dess framstellning | |
ES2129622T3 (es) | Receptores para interleuquina-10 de mamifero. | |
IL114668A0 (en) | Htk ligand | |
ES2188935T3 (es) | Polipeptido de fusion para influir sobre interacciones entre proteinas. | |
EP0504327A4 (en) | Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof | |
DK1129186T3 (da) | Et faktor VIII-polypeptid med faktor VIII:C-aktivitet | |
EP0185076A4 (ja) | ||
IL129527A0 (en) | A pharmaceutical composition containing soluble lymphotoxin-beta receptors | |
AU7657387A (en) | Apoprotein b-100 specific monoclonal antibodies | |
DE3268740D1 (en) | Rapid, quantitative peptide synthesis using mixed anhydrides | |
AU4157501A (en) | Her-2 binding antagonists | |
IL90997A0 (en) | Irreversible peptide ligands for bombesin receptors,their preparation and pharmaceutical compositions containing them | |
WO1992016623A3 (en) | Receptors for bombesin-like peptides | |
ATE28450T1 (de) | (alkylsulfonyl)methansulfonate als antikrebsmittel. | |
EA200400384A1 (ru) | Растворимый рецептор т-клетки |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20100125 |